We present the case of a 42-year-old woman with intractable eyelid
dermatitis. Patch testing revealed sensitization to 3-(dimethylamino)propylamine (
DMAPA).
DMAPA is an important etiology of
allergic contact dermatitis of the eyelids and face but is easily missed even with expanded-series patch testing. We also review the most common causative
allergens in eyelid
dermatitis cited in the literature over the past decade.
DMAPA is a
reagent used in the formation of
cocamidopropyl betaine (CAPB), a common additive to liquid
soaps, shampoos, and other cleansing products because of its utility as a
surfactant. Beginning in the 1980s, reports of
allergy to CAPB surfaced in the literature. Ultimately, a majority of patch testing studies have shown that clinical
allergy to CAPB-containing products actually reflects
allergy to contaminant
DMAPA in most cases. Amidoamine, another intermediate in the formation of CAPB, may also be implicated through a proposed mechanism of conversion to
DMAPA in the skin. When patch-testing for eyelid and facial
dermatitis, it is crucial to test with
DMAPA directly, not just with CAPB; unlike commercial-grade CAPB, the CAPB in patch test kits is ultrapure and does not contain contaminant
DMAPA.